Barbara Stypińska & Agnieszka Paradowska-Gorycka. (2015) Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus. International Journal of Molecular Sciences 16:10, pages 24194-24218.
Crossref
I. A. Rakityanskaya & T. S. Ryabova. (2012) Role of intrarenal mononuclear cells apoptosis in the mechanisms of pathogenesis of IgA nephropathy in patients with different age groups. Advances in Gerontology 2:3, pages 234-238.
Crossref
C.E. Lee, V. Prabhu & N.J. Slevin. (2011) Collagen Vascular Diseases and Enhanced Radiotherapy-induced Normal Tissue Effects — a Case Report and a Review of Published Studies. Clinical Oncology 23:2, pages 73-78.
Crossref
G. Domenico SebastianiM. Galeazzi. (2009) Infection—genetics relationship in systemic lupus erythematosus. Lupus 18:13, pages 1169-1175.
Crossref
N A Fathi, M R Hussein, H I Hassan, E Mosad, H Galal & N A Afifi. (2006) Glomerular expression and elevated serum Bcl-2 and Fas proteins in lupus nephritis: preliminary findings. Clinical and Experimental Immunology 146:2, pages 339-343.
Crossref
Stephanie Atencio, Hirofumi Amano, Shozo Izui & Brian L. Kotzin. (2004) Separation of the New Zealand Black Genetic Contribution to Lupus from New Zealand Black Determined Expansions of Marginal Zone B and B1a Cells. The Journal of Immunology 172:7, pages 4159-4166.
Crossref
S MIHARA, N SUZUKI, Y TAKEBA, K SOEJIMA & S YAMAMOTO. (2002) Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 129:2, pages 359-369.
Crossref
Huang-Ge Zhang, Martin Fleck, Hui-Chen Hsu, Carl K. EdwardsIIIIII, David T. Curiel, Tong Zhou & John D. Mountz. 2000. Gene Therapy in Inflammatory Diseases. Gene Therapy in Inflammatory Diseases
95
117
.
Masaki Yamaguchi, Steve Nadler, Jong-Wook Lee & H Joachim Deeg. (1999) Induction of negative regulators of haematopoiesis in human bone marrow cells by HLA-DR cross-linking. Transplant Immunology 7:3, pages 159-168.
Crossref
Su He Wang, Ronald J. Koenig, Thomas J. Giordano, Andrzej Myc, Norman W. Thompson & James R. BakerJr.Jr.. (1999) 1α,25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death*. Endocrinology 140:4, pages 1649-1656.
Crossref
R. Shai, F. P. Quismorio, L. Li, O.-J. Kwon, J. Morrison, D. J. Wallace, C. M. Neuwelt, C. Brautbar, W. J. Gauderman & C. O. Jacob. (1999) Genome-Wide Screen for Systemic Lupus Erythematosus Susceptibility Genes in Multiplex Families. Human Molecular Genetics 8:4, pages 639-644.
Crossref
Elisabeth M Messmer & C.Stephen Foster. (1999) Vasculitic Peripheral Ulcerative Keratitis. Survey of Ophthalmology 43:5, pages 379-396.
Crossref
Gwan Gyu Song, Martin Fleck, Jianguo Wu, Hui-Chen Hsu, Tong Zhou & John D. Mountz. 1999. Apoptosis and Inflammation. Apoptosis and Inflammation
181
212
.
Hui-Chen Hsu, Huang-Ge Zhang, Tong Zhou & John D. Mountz. 1999. Lupus. Lupus
671
693
.
Yasuhiko Munakata, Shin-ichiro Saito, Atsushi Hoshino, Tai Muryoi, Yasuhiko Hirabayashi, Shinobu Shibata, Toshihiko Miura, Tomonori Ishii, Tadao Funato & Takeshi Sasaki. (1998) Somatic mutation in autoantibody-associated VH genes of circulating IgM+IgD+ B cells. European Journal of Immunology 28:5, pages 1435-1444.
Crossref
Ruty Mehrian, Francisco P. Quismorio, Gideon Strassmann, Mary M. Stimmler, David A. Horwitz, Rodanthi C. Kitridou, W. James Gauderman, John Morrison, Chaim Brautbar & Chaim O. Jacob. (1998) Synergistic effect betweenIL-10 andbcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis & Rheumatism 41:4, pages 596-602.
Crossref
Susan M. Rakfal & Melvin Deutsch. (1998) Radiotherapy for Malignancies Associated with Lupus. American Journal of Clinical Oncology 21:1, pages 54-57.
Crossref
C. H. Weaver, R. Birch, F. A. Greco, L. Schwartzberg, B. McAneny, M. Moore, D. Oviatt, J. Redmond, C. George, T. Alberico, P. Johnson & C. D. Buckner. (2001) Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. British Journal of Haematology 100:2, pages 338-347.
Crossref
Noboru Suzuki, Motohide Ichino, Shoji Mihara, Sakae Kaneko & Tsuyoshi Sakane. (1998) Inhibition of FAS/FAS ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-FAS ligand autoantibodies in patients with systemic lupus erythematosus. Arthritis & Rheumatism 41:2, pages 344-353.
Crossref
N. Lawrence Edwards. 1998. Principles of Molecular Medicine. Principles of Molecular Medicine
299
307
.
Jianping Gao, Tammy A. Gelber-Schwalb, John V. Addeo & Michael E. Stern. 1998. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2
453
460
.
Konrad Schauenstein. 1998. Encyclopedia of Immunology. Encyclopedia of Immunology
275
280
.
SAZUKU NISITANI, MASAO MURAKAMI & TASUKU HONJO. (1997) Anti?Red Blood Cell Immunoglobulin Transgenic Mice.. Annals of the New York Academy of Sciences 815:1 B-Lymphocytes, pages 246-252.
Crossref
Colin Mitchell Hill & Joseph Lunec. (1996) The TNF-ligand and receptor superfamilies: Controllers of immunity and the Trojan horses of autoimmune disease?. Molecular Aspects of Medicine 17:5, pages 455-509.
Crossref
Q. R. Huang, D. Morris & N. Manolios. (1996) Evaluation of the BCL-2 gene locus as a susceptibility locus linked to the clinical expression of systemic lupus erythematosus (SLE). Rheumatology International 16:3, pages 121-124.
Crossref
Donald W. Nicholson. (1996) ICE/CED3-like Proteases as Therapeutic Targets for the Control of Inappropriate Apoptosis. Nature Biotechnology 14:3, pages 297-301.
Crossref
P Comfurius, EM Bevers, M Galli & RFA Zwaal. (2016) Regulation of Phospholipid Asymmetry and Induction of Antiphospholipid Antibodies. Lupus 4:1_suppl, pages S19-S22.
Crossref